Anthony S. Marucci

Exec. VP & Corporate Dev., Celldex Therapeutics.

Companies

Celldex TherapeuticsBoard member Aug 10, 2011 to now¹
Celldex TherapeuticsChief executive officer Jan 8, 2009 to now²
Celldex TherapeuticsPresident Jan 8, 2009 to now²
Celldex TherapeuticsExec. VP & Corporate Dev. Mar 17, 2008 to Mar 17, 2008³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Celldex Therapeutics CLDX40,284 shares⁴$1.1M at $27.53Nov 11, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 11, 2024Bought 11,500 shares at $26.82 of Celldex Therapeutics⁴
Aug 15, 2022Sold 120,000 shares at $37.66 of Celldex Therapeutics⁵
Aug 15, 2022Exercised options 45,000 shares at $9.02 of Celldex Therapeutics⁵
Aug 15, 2022Exercised options 75,000 shares at $2.78 of Celldex Therapeutics⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCelldex Therapeutics, Board member
2
SEC EDGARCelldex Therapeutics, Chief executive officer
3
SEC EDGARCelldex Therapeutics, Exec. VP & Corporate Dev.
4
SEC EDGARCelldex Therapeutics shares after the filing of Nov 11, 2024
5
SEC EDGARForm 4 filed Aug 17, 2022